Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Problems in the choice of a folate formulation for correction of folate status

Ших Е. В., Махова А. А.
Акушерство и гинекология
Вып. 8, С. 33-40
Опубликовано: 2018
Тип ресурса: Обзор

DOI:10.18565/aig.2018.8.33-40

Аннотация:
A systems analysis of the data available in the literature on the problem of choosing the optimal folate formulation in order to correct folate status in obstetric and gynecologic practice was carried out. There is plenty of evidence that increasing the folate status reduces the risk of neonatal neural tube defects. Higher folate intake through supplementation with folic acid (FA) or 5-methyltetrahydrofolate (L-methyl-THF) is recommended during pregravid preparation and early pregnancy. L-5-methyl-THF has a number of advantages over FA, since it is a physiological compound and has greater bioavailability. 5-methyl-THF is also available as a crystalline form of calcium salt (metafolin) that has the stability required for use as a supplement. When correcting the folate status in obstetric and gynecological practice, it is recommended that a choice should be made in favor of a formulation that has the best bioavailability, as seen in metafolin. © Bionika Media Ltd.
Ключевые слова:
Folic acid; Metafolin; Neonatal neural tube defects; Polymorphism in the folate system; Pregravid preparation
Язык текста: Русский
ISSN: 0300-9092
Ших Е. В. Евгения Валерьевна 1962-
Махова А. А. Анна Александровна 1983-
Shikh E. V. Evgeniya Valeryevna 1962-
Makhova A. A. Anna Aleksandrovna 1983-
Problems in the choice of a folate formulation for correction of folate status
Текст визуальный непосредственный
Акушерство и гинекология
Бионика Медиа
Вып. 8 С. 33-40
2018
Обзор
Folic acid Metafolin Neonatal neural tube defects Polymorphism in the folate system Pregravid preparation
A systems analysis of the data available in the literature on the problem of choosing the optimal folate formulation in order to correct folate status in obstetric and gynecologic practice was carried out. There is plenty of evidence that increasing the folate status reduces the risk of neonatal neural tube defects. Higher folate intake through supplementation with folic acid (FA) or 5-methyltetrahydrofolate (L-methyl-THF) is recommended during pregravid preparation and early pregnancy. L-5-methyl-THF has a number of advantages over FA, since it is a physiological compound and has greater bioavailability. 5-methyl-THF is also available as a crystalline form of calcium salt (metafolin) that has the stability required for use as a supplement. When correcting the folate status in obstetric and gynecological practice, it is recommended that a choice should be made in favor of a formulation that has the best bioavailability, as seen in metafolin. © Bionika Media Ltd.